Stephanie Scanlan learned the shocking shortages of essential chemotherapy drugs this spring. Two of the three drugs normally used to treat her rare bone cancer were too rare. She would have to move on without them. Ms. Scanlan, 56, head of a busy state office in Tallahassee, Florida, had sought the drugs for months as … [Read more…]
Illumina, the leading maker of gene sequencing machines, said Sunday it would sell Grail, a cancer test developer it bought for $7.1 billion in 2021. The move came two days after Illumina lost its case in a federal appeals court that largely upheld a Federal Trade Commission decision that Illumina should terminate its contract with … [Read more…]
These results are based on medium-sized trial data the companies released earlier this year that showed the combination’s effectiveness in the same 157 patients over a shorter period of time. After about two years, the vaccine and Keytruda reduced the risk of death or recurrence in melanoma patients by 44% and the risk of the … [Read more…]